These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9597239)

  • 41. Pneumococcal conjugate vaccine use in adults - Addressing an unmet medical need for non-bacteremic pneumococcal pneumonia.
    Sings HL
    Vaccine; 2017 Sep; 35(40):5406-5417. PubMed ID: 28602602
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 13-valent pneumococcal conjugate vaccine (PCV13).
    Jefferies JM; Macdonald E; Faust SN; Clarke SC
    Hum Vaccin; 2011 Oct; 7(10):1012-8. PubMed ID: 21941097
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of pneumococcal polysaccharide vaccine on nonbacteremic pneumococcal pneumonia.
    Weiser JN; Austrian R
    Clin Infect Dis; 2007 Apr; 44(8):1139-40; author reply 1140-1. PubMed ID: 17366469
    [No Abstract]   [Full Text] [Related]  

  • 44. Recurrent invasive pneumococcal disease in children--host factors and vaccination response.
    Ingels HA
    Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183055
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pneumococcal vaccine.
    LaForce FM
    Semin Respir Infect; 1989 Dec; 4(4):293-8. PubMed ID: 2697052
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Novel vaccine strategies with protein antigens of Streptococcus pneumoniae.
    Swiatlo E; Ware D
    FEMS Immunol Med Microbiol; 2003 Aug; 38(1):1-7. PubMed ID: 12900048
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pneumococcal serotype evolution in Western Europe.
    Tin Tin Htar M; Christopoulou D; Schmitt HJ
    BMC Infect Dis; 2015 Oct; 15():419. PubMed ID: 26468008
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of conjugate pneumococcal vaccines on the changing epidemiology of pneumococcal infections.
    Zangeneh TT; Baracco G; Al-Tawfiq JA
    Expert Rev Vaccines; 2011 Mar; 10(3):345-53. PubMed ID: 21434802
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of previous vaccination with pneumococcal conjugate vaccine on pneumococcal polysaccharide vaccine antibody responses.
    Schaballie H; Wuyts G; Dillaerts D; Frans G; Moens L; Proesmans M; Vermeulen F; De Boeck K; Meyts I; Bossuyt X
    Clin Exp Immunol; 2016 Aug; 185(2):180-9. PubMed ID: 26939935
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Pneumococcal vaccine in adults: comparison of recommendations and discussion of its role].
    Borsu K; Krammisch H; Franckh M; Giet D
    Rev Med Liege; 2010 Apr; 65(4):191-8. PubMed ID: 20499821
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Revaccination of renal transplant and hemodialysis recipients with pneumococcal vaccine.
    Linnemann CC; First MR; Schiffman G
    Arch Intern Med; 1986 Aug; 146(8):1554-6. PubMed ID: 3524494
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Streptococcus pneumoniae Type 2 Oligosaccharide Glycoconjugate Elicits Opsonic Antibodies and Is Protective in an Animal Model of Invasive Pneumococcal Disease.
    Emmadi M; Khan N; Lykke L; Reppe K; G Parameswarappa S; Lisboa MP; Wienhold SM; Witzenrath M; Pereira CL; Seeberger PH
    J Am Chem Soc; 2017 Oct; 139(41):14783-14791. PubMed ID: 28945368
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antibody response to polyvalent pneumococcal polysaccharide vaccine in diabetics.
    Beam TR; Crigler ED; Goldman JK; Schiffman G
    JAMA; 1980 Dec; 244(23):2621-4. PubMed ID: 7431608
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tolerability and immunogenicity of an eleven valent mixed carrier Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid or tetanus protein conjugate vaccine in Finnish and Israeli infants.
    Dagan R; Kayhty H; Wuorimaa T; Yaich M; Bailleux F; Zamir O; Eskola J
    Pediatr Infect Dis J; 2004 Feb; 23(2):91-8. PubMed ID: 14872172
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pneumococcal vaccine: overcoming barriers to use.
    Tamblyn SE
    CMAJ; 1998 Jan; 158(1):87-8. PubMed ID: 9475917
    [No Abstract]   [Full Text] [Related]  

  • 56. New vaccines for the prevention of pneumococcal infections.
    Käyhty H; Eskola J
    Emerg Infect Dis; 1996; 2(4):289-98. PubMed ID: 8969245
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of high-valency pneumococcal conjugate vaccines on invasive pneumococcal disease in children in SpIDnet countries: an observational multicentre study.
    Savulescu C; Krizova P; Lepoutre A; Mereckiene J; Vestrheim DF; Ciruela P; Ordobas M; Guevara M; McDonald E; Morfeldt E; Kozakova J; Varon E; Cotter S; Winje BA; Munoz-Almagro C; Garcia L; Castilla J; Smith A; Henriques-Normark B; Celentano LP; Hanquet G;
    Lancet Respir Med; 2017 Aug; 5(8):648-656. PubMed ID: 28359798
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pneumococcal polysaccharide vaccine. Centers for Disease Control, H.E.W., Public Health Service, Atlanta, GA.
    Conn Med; 1981 Dec; 45(12):779-81. PubMed ID: 6273062
    [No Abstract]   [Full Text] [Related]  

  • 59. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1997 Apr; 46(RR-8):1-24. PubMed ID: 9132580
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pneumococcal vaccine.
    Stollerman GH
    JAMA; 1982 Apr; 247(13):1809-10. PubMed ID: 7062485
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.